SAN DIEGO, Feb. 1 /PRNewswire-FirstCall/ -- Biosite(R) Incorporated , today announced that, in accordance with Nasdaq Marketplace Rule 4350, 30 non-officer employees were granted inducement stock options covering an aggregate of 47,625 shares of common stock. These options were granted pursuant to Nasdaq Marketplace Rule 4350 (i)(1)(A)(iv) with the following terms: each option has been classified as a non-qualified stock option, has an exercise price equal to the fair market value on the grant date, has a ten-year term, and vests in 16 equal quarterly installments over four years (on each quarterly anniversary of the applicable vesting commencement date).
About Biosite Incorporated
Biosite Incorporated is a leading bio-medical company commercializing proteomics discoveries for the advancement of medical diagnosis. The Company’s products contribute to improvements in medical care by aiding physicians in the diagnosis of critical diseases and health conditions. The Biosite(R) Triage(R) rapid diagnostic tests are used in more than 50 percent of U.S. hospitals and in more than 60 international markets. Information on Biosite can be found at www.biosite.com.
Biosite(R) Triage(R) and New Dimensions in Diagnosis(R) are registered trademarks of Biosite Incorporated. The Company’s logo is a trademark of Biosite Incorporated.
Biosite Incorporated
CONTACT: Nadine Padilla, Vice President, Corporate & Investor Relations,Biosite Incorporated, +1-858-805-2820, npadilla@biosite.com
Web site: http://www.biosite.com/
Company News On-Call: http://www.prnewswire.com/comp/116737.html /
